Assignee
JUNO THERAPEUTICS INC
US·62 granted patents·110 pending applications·175 citations·filing 2015–2025
Top patents by PatentIndex Score
172 records- 0194US12208137B2Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapyJUNO THERAPEUTICS INC·Filed 2023·Granted Jan 28, 2025·4 cites·10 claims
- 0294US11400115B2Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapyJUNO THERAPEUTICS INC·Filed 2015·Granted Aug 2, 2022·18 cites·28 claims
- 0394US10738278B2Engineered cells for adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2015·Granted Aug 11, 2020·8 cites·21 claims
- 0493US12296010B2Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapyJUNO THERAPEUTICS INC·Filed 2024·Granted May 13, 2025·1 cites·20 claims
- 0593US10889652B2Antibodies and chimeric antigen receptors specific for ROR1JUNO THERAPEUTICS INC·Filed 2018·Granted Jan 12, 2021·9 cites·29 claims
- 0692US11944647B2Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2022·Granted Apr 2, 2024·5 cites·20 claims
- 0792US11413310B2Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Aug 16, 2022·12 cites·55 claims
- 0892US10533055B2Antibodies and chimeric antigen receptors specific for CD19JUNO THERAPEUTICS INC·Filed 2015·Granted Jan 14, 2020·16 cites·48 claims
- 0991US11066475B2Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotidesJUNO THERAPEUTICS INC·Filed 2018·Granted Jul 20, 2021·10 cites·23 claims
- 1090US10507219B2Methods and compositions for dosing in adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2015·Granted Dec 17, 2019·10 cites·38 claims
- 1190US2025387482A1Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapyJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1289US11623961B2Antibodies and chimeric antigen receptors specific for B-cell maturation antigenJUNO THERAPEUTICS INC·Filed 2018·Granted Apr 11, 2023·7 cites·35 claims
- 1389US10786533B2Engineered cells for adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2016·Granted Sep 29, 2020·4 cites·24 claims
- 1488US11020429B2Vectors and genetically engineered immune cells expressing metabolic pathway modulators and uses in adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2016·Granted Jun 1, 2021·9 cites·49 claims
- 1587US12193994B2Combination of a cell therapy and a gamma secretase inhibitorJUNO THERAPEUTICS INC·Filed 2018·Granted Jan 14, 2025·4 cites·32 claims
- 1687US10428351B2Methods for transduction and cell processingJUNO THERAPEUTICS INC·Filed 2015·Granted Oct 1, 2019·13 cites·42 claims
- 1787US10363269B2Modified hepatitis post-transcriptional regulatory elementsJUNO THERAPEUTICS INC·Filed 2016·Granted Jul 30, 2019·8 cites·46 claims
- 1886US11919970B2Antibodies and chimeric antigen receptors specific for ROR1JUNO THERAPEUTICS INC·Filed 2020·Granted Mar 5, 2024·1 cites·40 claims
- 1986US11851678B2Methods for producing genetically engineered cell compositions and related compositionsJUNO THERAPEUTICS INC·Filed 2018·Granted Dec 26, 2023·9 cites·38 claims
- 2085US12215348B2Methods for producing genetically engineered cell compositions and related compositionsJUNO THERAPEUTICS INC·Filed 2023·Granted Feb 4, 2025·1 cites·26 claims
- 2185US11072660B2HPV-specific binding moleculesJUNO THERAPEUTICS INC·Filed 2017·Granted Jul 27, 2021·4 cites·34 claims
- 2283US11815514B2Methods and compositions related to toxicity associated with cell therapyJUNO THERAPEUTICS INC·Filed 2016·Granted Nov 14, 2023·2 cites·31 claims
- 2383US11633426B2Methods and compositions for dosing in adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2019·Granted Apr 25, 2023·1 cites·43 claims
- 2483US11266739B2Methods and compositions for adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2015·Granted Mar 8, 2022·2 cites·45 claims
- 2583US2025312446A1Methods and compositions for adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2682US12583904B2Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2024·Granted Mar 24, 2026·0 cites·18 claims
- 2782US2024066122A1Methods and compositions for adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2881US11561219B2Methods of enumerating particles present in a cell compositionJUNO THERAPEUTICS INC·Filed 2017·Granted Jan 24, 2023·3 cites·26 claims
- 2980US11564946B2Methods associated with tumor burden for assessing response to a cell therapyJUNO THERAPEUTICS INC·Filed 2018·Granted Jan 31, 2023·2 cites·40 claims
- 3080US2023090176A1Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapyJUNO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3178US2024115612A1Articles of manufacture and methods for treatment using adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3278US2024368625A1Methods and compositions for preparing genetically engineered cellsJUNO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3376US12168027B2Methods associated with tumor burden for assessing response to a cell therapyJUNO THERAPEUTICS INC·Filed 2022·Granted Dec 17, 2024·0 cites·37 claims
- 3476US11590167B2Methods and compositions for use of therapeutic T cells in combination with kinase inhibitorsJUNO THERAPEUTICS INC·Filed 2017·Granted Feb 28, 2023·2 cites·37 claims
- 3576US11535903B2Methods and reagents for assessing the presence or absence of replication competent virusJUNO THERAPEUTICS INC·Filed 2019·Granted Dec 27, 2022·2 cites·25 claims
- 3676US11421287B2Methods for assessing the presence or absence of replication competent virusJUNO THERAPEUTICS INC·Filed 2017·Granted Aug 23, 2022·1 cites·35 claims
- 3776US2024018256A1Antibodies and chimeric antigen receptors specific for cd19JUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3875US12161670B2Phenotypic markers for cell therapy and related methodsJUNO THERAPEUTICS INC·Filed 2018·Granted Dec 10, 2024·1 cites·20 claims
- 3975US2025152712A1Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapyJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4075US2024151713A1Articles of manufacture and methods related to toxicity associated with cell therapyJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4175US2022280642A1Methods and compositions for adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 4275US2025161450A1Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapyJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4375US2023285463A1Methods and compositions for dosing in adoptive cell therapyJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4475US2025161449A1Methods for isolating, culturing, and genetically engineering immune cell populations for adoptive therapyJUNO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4574US12379375B2Methods for assessing cell surface glycosylationJUNO THERAPEUTICS INC·Filed 2023·Granted Aug 5, 2025·0 cites·18 claims
- 4674US11827714B2Antibodies and chimeric antigen receptors specific for CD19JUNO THERAPEUTICS INC·Filed 2019·Granted Nov 28, 2023·0 cites·31 claims
- 4773US2024011051A1Methods for transduction and cell processingJUNO THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 4873US2025090542A1Combination of a cell therapy and a gamma secretase inhibitorJUNO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 4972US12258580B2Process for generating therapeutic compositions of engineered cellsJUNO THERAPEUTICS INC·Filed 2018·Granted Mar 25, 2025·2 cites·41 claims
- 5072US11952408B2HPV-specific binding moleculesJUNO THERAPEUTICS INC·Filed 2018·Granted Apr 9, 2024·1 cites·46 claims
Showing the top 50 of 172 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when JUNO THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →